Brief: Oragenics Announces Health And Disability Ethics Committee Submission
09/04/2025 14:11
April 9 (Reuters) - Oragenics Inc OGEN.A: ORAGENICS, INC. ANNOUNCES HEALTH AND DISABILITY ETHICS COMMITTEE SUBMISSION FOR PHASE IIA CONCUSSION TRIAL Source text: ID:nGNX7jmHc Further company coverage: OGEN.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing